TerminatedEarly Phase 1NCT05507996
Recombinant Adeno-associated Virus Administration for Patients With Menkes Syndrome
Studying Menkes disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kunming Hope of Health Hospital
- Principal Investigator
- Li LiKunming Hope of Health Hospital
- Intervention
- Recombinant adeno-associated virus administration(drug)
- Enrollment
- 1 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2022
Study locations (1)
- Kunming Hope of Health Hospital, Kunming, Yunnan, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05507996 on ClinicalTrials.govOther trials for Menkes disease
Additional recruiting or active studies for the same condition.